Do cannabinoid agonists used for the treatment of refractory lower urinary tract symptoms in patients with neurogenic detrusor overactivity have an effect on bladder afferent pathways?

Katafygiotis S1, Kavia R2, Gonzales G2, Dimitriadis F3, Malousi A4, Ioannidis E5, Fowler C J2, Lambropoulos A1, Apostolidis A3

Abstract Category

Neurourology: Basic Science

Abstract 34
Neurourology
Scientific Podium Poster Session 4
Wednesday 31st August 2011
14:45 - 14:50
Hall P2
1. 1st Department of Obstetrics & Gynaecology, Molecular Biology Lab, Aristotle University of Thessaloniki, Greece, 2. Department of UroNeurology, Institute of Neurology, UCL, London,UK, 3. 2nd Department of Urology & Centre for study of Continence and Pelvic Floor Disorders, Aristotle University of Thessaloniki, Greece, 4. Lab of Medical Informatics, Aristotle University of Thessaloniki, Greece, 5. 2nd Department of Urology, Aristotle University of Thessaloniki, Greece
Presenter
A

Apostolos Apostolidis
2nd Department of Urology & Centre for study of Continence and Pelvic Floor Disorders, Aristotle University of Thessaloniki, Greece
Links

Abstract

20/11/2024 08:00:02